Screener
Arcus Biosciences RCUS Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
FAQ
- What is Arcus Biosciences's accrued expenses?
- Arcus Biosciences (RCUS) reported accrued expenses of $21M in Q2 2026.
- How has Arcus Biosciences's accrued expenses changed year-over-year?
- Arcus Biosciences's accrued expenses decreased by 0.0% year-over-year, from $21M to $21M.
- What is the long-term trend for Arcus Biosciences's accrued expenses?
- Over 5 years (2020 to 2025), Arcus Biosciences's accrued expenses has grown at a 56.1% compound annual growth rate (CAGR), from $3.57M to $33M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Arcus Biosciences's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude